Palvella Therapeutics (PVLA) Stock Chart & Stock Price History $20.62 -0.72 (-3.37%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Palvella Therapeutics Stock Price Performance The Palvella Therapeutics (PVLA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 71.83%. In the past month, the stock has decreased 13.07%, reflecting recent market activity. As of the latest close, Palvella Therapeutics traded at $21.34 with a market cap of $235.94 million and volume of 50,390 shares. Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.49%1 Month Performance-13.07%3 Month Performance-26.17%Year-To-Date Performance+71.83% PVLA Stock Chart for Thursday, June, 26, 2025 PVLA Chart by TradingView Palvella Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/25/2025$22.06$21.34-3.26%$22.88$21.3050,390 shs$235.94 million06/24/2025$22.54$22.06-2.13%$23.38$21.8658,843 shs$243.98 million06/23/2025$22.05$22.54+2.22%$23.53$21.71178,383 shs$249.29 million06/20/2025$20.51$22.05+7.51%$22.72$20.7981,392 shs$243.87 million06/19/2025$20.51$20.51$22.03$20.2042,590 shs$226.84 million06/18/2025$21.24$20.51-3.44%$22.03$20.2042,590 shs$226.84 million06/17/2025$23.42$21.24-9.31%$23.56$21.1589,709 shs$234.83 million06/16/2025$25.05$23.42-6.51%$25.50$23.4053,739 shs$258.93 million06/13/2025$26.42$25.05-5.19%$26.49$24.65223,837 shs$276.95 million06/12/2025$25.32$26.42+4.34%$26.65$24.4066,022 shs$292.10 million Get the Latest News and Ratings for PVLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/11/2025$26.23$25.32-3.47%$26.45$24.74101,624 shs$279.94 million06/10/2025$26.63$26.23-1.50%$27.20$26.0488,973 shs$290.00 million06/09/2025$25.40$26.63+4.84%$26.93$25.0278,009 shs$294.42 million06/06/2025$23.49$25.40+8.13%$25.88$23.5248,489 shs$280.82 million06/05/2025$23.81$23.49-1.34%$24.23$22.8648,196 shs$259.71 million06/04/2025$24.44$23.81-2.58%$24.94$22.7888,624 shs$263.24 million06/03/2025$25.14$24.44-2.78%$25.15$23.7667,878 shs$270.21 million06/02/2025$24.30$25.14+3.46%$26.74$23.65165,220 shs$277.95 million05/30/2025$24.78$24.30-1.94%$25.50$24.1383,965 shs$268.66 million05/29/2025$23.83$24.78+3.99%$25.31$24.0853,591 shs$273.97 million05/28/2025$22.94$23.83+3.88%$24.19$22.3035,959 shs$263.46 million05/27/2025$23.72$22.94-3.29%$24.81$22.9048,410 shs$253.63 million05/26/2025$23.72$23.72$24.39$21.96138,230 shs$262.25 million Related Companies RCUS Stock Chart AVDL Stock Chart MLYS Stock Chart NRIX Stock Chart ZYME Stock Chart PRAX Stock Chart PHVS Stock Chart ARDX Stock Chart AVBP Stock Chart OCS Stock Chart Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PVLA) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy July is critical for your stocksBig Study Shows Stocks Extremely Likely to Crash in 2026? Legendary quant analyst Marc Chaikin says in 50 y...Chaikin Analytics | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.